Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 2974-2982

  Sheikh, N A ^a   Rajananthanan, P ^a   Attard, G S ^b   Morrow, W J W ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

CTL; Immunization; Peptide; Soluble protein

Indexed keywords

ALUMINUM HYDROXIDE; CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; GLYCOLIPID; IMMUNOLOGICAL ADJUVANT; PROVAX; TOMATINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; EMULSION; FEMALE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD8; CYTOTOXICITY, IMMUNOLOGIC; EGG PROTEINS; EPITOPES, T-LYMPHOCYTE; FEMALE; FREUND'S ADJUVANT; GLYCOLIPIDS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC; TOMATINE;

EID: 0033529479     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00173-5     Document Type: Article

References (25)

1. Germain R. MHC dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:1994;287.
2. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Ann Rev Immunol. 16:1998;323.
3. Nelson C., Petzold S., Unanue E. Peptides determine the lifespan of MHC class II molecules in the antigen presenting cell. Nature. 371:1994;250.
4. Lindner R., Unanue E. Distinct antigen MHC class II complexes generated by separate processing pathways. The EMBO Journal. 15:1994;6910.
5. + cytotoxic T-cell responses? A paradox revisited. Immunology Today. 14:1993;344.
6. Sheikh N., Rajananthanan P., Morrow W.J.W. Immunological adjuvants: mechanisms of action and clinical applications. Exp Opin Investi Drugs. 5:1996;1079.
7. Stewart-Tull DES. The Theory and Practical Application of Adjuvants, Wiley, Chichester, 1994, p. 1.
8. Raychaudhuri S., Tonks M., Carbone F., Ryskamp T., Morrow W.J.W., Hanna N. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc. Natl. Acad. Sci. -USA. 89:1992;8308.
9. Nair S., Zhou X., Huang L., Rouse B. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polysines. J. Immunol. Meth. 152:1992;237.
10. Harding C., Collins D., Kanagawa S., Unanue E. Liposome encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:1991;2860.
11. Harihan K., Braslawsky G., Black A., Raychaudhuri S., Hanna N. The induction of cytotoxic T cells and tumour regression by soluble antigen formulation. Cancer Res. 55:1995;3486.
12. Rajananthanan P., Attard G.S., Sheikh N.A., Morrow W.J.W. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses. Vaccine. 17:1999;715.
13. Levin J., Bang F.B. Clottable protein in Limulus: Its localization and kinetics of its coagulation by endooxin. Thromb. Diath. Haemorrh. 19:1968;168.
14. Moore M., Carbone F., Bevan M. Introduction of soluble protein into the class I pathway of antigen processing presenting. Cell. 54:1988;777.
15. Cobbold S., Jaysuriya A., Nash A., Prosper T., Waldman H. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature. 312:1984;548.
16. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., Germain R.N. Localization, quantitation and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 6:1997;715.
17. Cooper J.F., Hochstein H.D., Seligmann E.B. The Limulus test for endotoxin (pyrogen) in radiopharmaceuticals and biologicals. Bull. Parenter. Drug. Assoc. 26:1972;153.
18. Hunter R., Strickland F., Kezdy F. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance. J. Immunol. 127:1981;1244.
19. Stewart-Tull DES. The Theory and Practical Application of Adjuvants, Wiley, Chichester, 1996, p. 171.
20. Attard G.S., Blackaby W.P., Leach A.R. The aggregation behaviour of two structurally isomeric glycolipids. Chem. Phys. Lipids. 74:1994;83-91.
21. Keukens E.A., de Vrije T., Van Den Boom C., de Waard P., Plasman H.H., Thiel F., Chupin V., Jongen W.M., de Kruijff B. Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta. 1240:1995;216.
22. Keukens E.A., de Vrije T., Fabrie C.H., Demel R.A., Jongen W.M., de Kruijff B. Dual specificity of sterol-mediated glycoalkoloid induced membrane disruption. Biochim Biophys Acta. 1110:1992;127.
23. Keukens E.A., de Vrije T., Jansen L.A., de Boer H., Janssen M., de Kroon A.I., Jongen W.M., de Kruijff B. Glycoalkoloids selectively permeabilize cholesterol containing membranes. Biochim Biophys Acta. 1279:1996;243.
24. Blankemeyer J.T., White J.B., Stringer B.K., Friedman M. Effect of alpha-tomatine on membrane potential of frog embryos and active transport of ions in frog skin. Food Chem. Toxicol. 35:1997;639.
25. + cytotoxic T lymphocytes. Scand. J. Immunol. 42:1995;66.